Clinical outcomes after revision knee arthroplasty due to periprosthetic joint infection: A single-centre study of 359 knees at a high-volume centre with a minimum of one year follow-up

因假体周围关节感染而行翻修膝关节置换术后的临床结果:一项在高容量中心开展的单中心研究,纳入359例膝关节,随访时间至少一年。

阅读:1

Abstract

PURPOSE: Decisions on the treatment of periprosthetic joint infection (PJI) are typically guided by established algorithms. However, as these algorithms often lack substantial supporting evidence, this study aimed to evaluate 1-year survival rates and compare different surgical approaches. METHODS: In this single-centre retrospective cohort study, all revisions of the knee due to PJI with at least 1 year of follow-up performed between January 2008 and September 2021 were identified. In total, 141 debridement, antibiotics, and implant retentions (DAIRs), 98 one-stage, and 120 two-stage revisions were performed. Infections were classified as early, acute hematogenous, or chronic infections. Survival was calculated using the Kaplan-Meier method and the cumulative incidence function. Predictors of outcomes were examined with Fine-Gray regression and Cox proportional hazards regression, and subdistribution hazard ratios (sdHR) and adjusted hazard ratios (aHR) with 95% confidence intervals (CIs) were calculated. RESULTS: At 1-year follow-up, 23% (CI 19%-27%) of patients had undergone a reoperation, and 4% (CI 2%-6%) had died. The risk of reoperation was largest after two-stage revision (28%, CI 20%-36%) and smallest after one-stage revision (15%, CI 9%-23%). For every infection type, the failure rates at one-year follow-up favoured one-stage revision over two-stage revision. Higher ASA-scores increased the risk of death (aHR 1.7, CI 1.1-2.5 per one-unit increase). CONCLUSION: The risk of failure after one-year follow-up is high after revision for periprosthetic joint infection. The lowest risk was observed after one-stage revision; however, this may partly reflect patient selection, as one-stage revision may not be suitable for all patients. LEVEL OF EVIDENCE: Level III, retrospective comparative study.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。